DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population

Neuroscience Letters

Volumn 368, Issue 3, 2004, Pages 269-273

  Serretti, Alessandro ^a,f   Lorenzi, Cristina ^a,b   Mandelli, Laura ^a   Cichon, Sven ^c   Schumacher, Johannes ^d   Nöthen, Markus M ^c   Rietschel, Marcella ^e   Tullius, Monja ^d   Ohlraun, Stephanie ^e  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF BONN   (Germany)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Dopamine receptors; Genetics; Manic depressive disorder; Mood disorders; Phenotype; Polymorphism; Schizophrenia

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EXON; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; ALLELES; CHI-SQUARE DISTRIBUTION; EXONS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; VARIATION (GENETICS);

EID: 4544329457     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.036     Document Type: Article

References (58)

1. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 52:1995;341-351
2. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem. 65:1995;1157-1165
3. Baldessarini R.J., Tarazi F.I. Brain dopamine receptors: a primer on their current status. Harv. Rev. Psychiatry. 3:1996;301-325
4. Barbini B., Scherillo P., Benedetti F., Crespi G., Colombo C., Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int. Clin. Psychopharmacol. 12:1997;109-112
5. Burke J.G., Murphy B.M., Bray J.C., Walsh D., Kendler K.S. Clinical similarities in siblings with schizophrenia. Am. J. Med. Genet. 67:1996;239-243
6. Calabrese J., Kimmel S., Woyshville M., Rapport D., Faust C., Thompson P., Meltzer H. Clozapine for treatment-refractory mania. Am. J. Psychiatry. 153:1996;759-764
7. Cardno A.G., Jones L.A., Murphy K.C., Asherson P., Scott L.C., Williams J., Owen M.J., McGuffin P. Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophr. Res. 22:1996;233-239
8. Chua S.E., Wright I.C., Poline J.B., Liddle P.F., Murray R.M., Frackowiak R.S., Friston K.J., McGuire P.K. Grey matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images. Br. J. Psychiatry. 170:1997;406-410
9. J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates, Hillsdale, New Jersey, 1988, pp. 8-14.
10. Coryell W., Akiskal H.S., Leon A.C., Winokur G., Maser J.D., Mueller T.I., Keller M.B. The time course of nonchronic major depressive disorder. Uniformity across episodes and samples. National Institute of Mental Health Collaborative Program on the Psychobiology of Depression - Clinical Studies. Arch. Gen. Psychiatry. 51:1994;405-410
11. Craddock M., Asherson P., Owen M.J., Williams J., McGuffin P., Farmer A.E. Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br. J. Psychiatry. 169:1996;58-63
12. Endicott J., Spitzer R. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844
13. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia - psychopathological and behavioral correlates. Eur. Psychiatry. 17:2002;9-16
14. Helmeste D.M., Tang S.W. Dopamine D4 receptors. Jpn. J. Pharmacol. 82:2000;1-14
15. Jones H.M., Pilowsky L.S. Dopamine and antipsychotic drug action revisited. Br. J. Psychiatry. 181:2002;271-275
16. Jovanovic V., Guan H.C., Van Tol H.H. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics. 9:1999;561-568
17. Kendler K.S., Karkowski-Shuman L., O'Neill F.A., Straub R.E., MacLean C.J., Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish study of high-density schizophrenia families: evidence for possible etiologic heterogeneity. Am. J. Psychiatry. 154:1997;191-198
18. Lahiri D.K., Nurnberger J.I.J. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 19:1991;5444
19. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry. 39:1982;879-883
20. Lerer B., Macciardi F., Segman R.H., Adolfsson R., Blackwood D., Blairy S., Del Favero J., Dikeos D.G., Kaneva R., Lilli R., Massat I., Milanova V., Muir W., Noethen M., Oruc L., Petrova T., Papadimitriou G.N., Rietschel M., Serretti A., Souery D., Van Gestel S., Van Broeckhoven C., Mendlewicz J. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiatry. 6:2001;579-585
21. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H., Kidd K.K., Livak K.J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet. 2:1993;767-773
22. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br. J. Psychiatry. 151:1987;145-151
23. Liddle P.F., Barnes T.R.E. Syndromes of chronic schizophrenia. Br. J. Psychiatry. 157:1990;558-561
24. Loftus J., DeLisi L.E., Crow T.J. Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder. Psychiatry Res. 80:1998;101-111
25. Lung F.W., Tzeng D.S., Shu B.C. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. Schizophr. Res. 57:2002;239-245
26. Macciardi F., Petronis A., Van Tol H., Marino C., Cavallini M., Smeraldi E., Kennedy J. Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. Arch. Gen. Psychiatry. 51:1994;288-293
27. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Brain Res. Mol. Brain Res. 29:1995;157-162
28. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J. Neurochem. 66:1996;915-919
29. Maziade M., Bouchard S., Gingras N., Charron L., Cardinal A., Roy M.A., Gauthier B., Tremblay G., Cote S., Fournier C., Boutin P., Hamel M., Merette C., Martinez M. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: postnegative distinction and childhood predictors of adult outcome. Br. J. Psychiatry. 169:1996;371-378
30. Maziade M., Roy M.A., Martinez M., Cliche D., Fournier J.P., Garneau Y., Nicole L., Montgrain N., Dion C., Ponton A.M. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am. J. Psychiatry. 152:1995;1458-1463
31. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry. 48:1991;764-770
32. Meador-Woodruff J.H., Damask S.P., Wang J., Haroutunian V., Davis K.L., Watson S.J. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 15:1996;17-29
33. Meador-Woodruff J.H., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch. Gen. Psychiatry. 54:1997;1089-1095
34. Merchant K.M., Gill G.S., Harris D.W., Huff R.M., Eaton M.J., Lookingland K., Lutzke B.S., McCall R.B., Piercey M.F., Schreur P.J., Sethy V.H., Smith M.W., Svensson K.A., Tang A.H., Vonvoigtlander P.F., Tenbrink R.E. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. J. Pharmacol. Exp. Ther. 279:1996;1392-1403
35. Mulcrone J., Kerwin R.W. The regional pattern of D4 gene expression in human brain. Neurosci. Lett. 234:1997;147-150
36. Murray A., Hyde T., Knable M., Herman M., Bigelow L., Carter J., Weinberger D., Kleinman J. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci. 15:1995;2186-2191
37. Pania L., Gessab G.L. Dopaminergic deficit and mood disorders. Int. Clin. Psychopharmacol. 17(Suppl. 4):2002;S1-S7. discussion S7
38. Peralta V., Cuesta M., De Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol. Psychiatry. 36:1994;726-736
39. Peralta V., de Leon J., Cuesta M.J. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br. J. Psychiatry. 161:1992;335-343
40. Petronis A., Macciardi F., Athanassiades A., Paterson A., Verga M., Meltzer H., Cola P., Buchanan J., Van Tol H., Kennedy J. Association study between the dopamine D4 receptor gene and schizophrenia. Am. J. Med. Genet. 60:1995;452-455
41. Roberts D.A., Balderson D., Pickering-Brown S.M., Deakin J.F., Owen F. The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls. Schizophr. Res. 20:1996;171-174
42. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., Fang Y., Larson J.L., McDougall J.A., Chester J.A., Saez C., Pugsley T.A., Gershanik O., Low M.J., Grandy D.K. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell. 90:1997;991-1001
43. Seeman P., Guan H., Van Tol H. Dopamine D4 receptors elevated in schizofrenia. Nature. 365:1993;441-445
44. Serretti A., Lilli R., Lorenzi C., Lattuada E., Smeraldi E. DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2011 affected subjects. Am. J. Med. Genet. 105:2001;283-290
45. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Smeraldi E. Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Res. 80:1998;129-136
46. Serretti A., Macciardi F., Smeraldi E. Identification of symptomatologic patterns common to major psychoses: proposal for a phenotype definition. Am. J. Med. Genet. 67:1996;393-400
47. Stefanis N.C., Bresnick J.N., Kerwin R.W., Schofield W.N., McAllister G. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Brain Res. Mol. Brain Res. 53:1998;112-119
48. Sumiyoshi T., Stockmeier C., Overholser J., Thompson P., Meltzer H. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res. 681:1995;109-116
49. Tang A.H., Franklin S.R., Himes C.S., Smith M.W., Tenbrink R.E. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J. Pharmacol. Exp. Ther. 281:1997;440-447
50. Van Os J., Fahy T.A., Jones P., Harvey I., Sham P., Lewis S., Bebbington P., Toone B., Williams M., Murray R. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol. Med. 26:1996;161-176
51. Van Os J., Marcelis M., Sham P., Jones P., Gilvarry K., Murray R. Psychopathological syndromes and familial morbid risk of psychosis. Br. J. Psychiatry. 170:1997;241-246
52. Van Tol H., Bunzow J., Guan H., Sunahara R., Seeman P., Niznik H., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614
53. Van Tol H., Caren M., Guan H., Ohara K., Bunzow J., Civelli O., Kennedy J., Seeman P., Niznik H., Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature. 358:1992;149-152
54. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669
55. Williams J., Farmer A.E., Ackenheil M., Kaufmann C.A., McGuffin P. A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system. Psychol. Med. 26:1996;775-783
56. P. Willner, Dopaminergic mechanisms in depression and mania, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 921-931.
57. Wong A.H., Buckle C.E., Van Tol H.H. Polymorphisms in dopamine receptors: what do they tell us? Eur. J. Pharmacol. 410:2000;183-203
58. Zarate C.A. Jr., Tohen M., Banov M.D., Weiss M.K., Cole J.O. Is clozapine a mood stabilizer? J. Clin. Psychiatry. 56:1995;108-112